Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.89 +0.06 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) EV to EBITDA (2022 - 2023)

Updated

Cullinan Therapeutics' EV to EBITDA was 0.10 in Q1 2023, down 6.2% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) EV to EBITDA (2022 - 2023) Analysis & Trends

On a trailing twelve-month basis, Cullinan Therapeutics' EV to EBITDA was -14.32 through Mar 31, 2023; for FY2022, it was 0.11.

  • Quarterly EV to EBITDA has moved between -0.19 (Q2 2022) and 0.11 (Q4 2022) over five years.
  • Per Business Quant data, CGEM's EV to EBITDA in the three quarters before Q1 2023 was 0.11 (Q4 2022), 0.07 (Q3 2022) and -0.19 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cullinan Therapeutics 919.35 Mn 584.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.10
Dec 31, 2022 0.11
Sep 30, 2022 0.07
Jun 30, 2022 -0.19
API Access

Cullinan Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CGEM&period=max&api_key=YOUR_API_KEY